Inventor · disambiguated record
Youe-Kong Shue
Also filed as: SHUE YOUE-KONG
21 granted patents·15 pending applications·299 citations·filing 1991–2018
96Inventor score
Top patents by PatentIndex Score
36 records- 0196US7378508B2Polymorphic crystalline forms of tiacumicin BOPTIMER PHARMACEUTICALS INC·Filed 2007·Granted May 27, 2008·29 cites·20 claims
- 0291US8012943B2Antibacterial agentsOPTIMER PHARMACEUTICALS INC·Filed 2009·Granted Sep 6, 2011·15 cites·25 claims
- 0389US8859510B2Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereofCHIU YU-HUNG·Filed 2008·Granted Oct 14, 2014·6 cites·13 claims
- 0489US8343936B2Antibacterial agentsOPTIMER PHARMACEUTICALS INC·Filed 2011·Granted Jan 1, 2013·10 cites·7 claims
- 0589US7601695B2Antibacterial agentsOPTIMER PHARMACEUTICALS INC·Filed 2004·Granted Oct 13, 2009·34 cites·30 claims
- 0688US8883986B2Macrolide polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereofCHIU YU-HUNG·Filed 2009·Granted Nov 11, 2014·5 cites·14 claims
- 0788US8518899B2Macrocyclic polymorphs, compositions comprising such polymorphs and methods of use and manufacture thereofCHIU YU-HUNG·Filed 2009·Granted Aug 27, 2013·6 cites·24 claims
- 0887US7863249B2Macrolide polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereofOPTIMER PHARMACEUTICALS INC·Filed 2008·Granted Jan 4, 2011·10 cites·17 claims
- 0985US9200026B2Antibacterial agentsMERCK SHARP & DOHME·Filed 2012·Granted Dec 1, 2015·8 cites·20 claims
- 1083US8044030B2Antibiotic macrocycle compounds and methods of manufacture and use thereofOPTIMER PHARMACEUTICALS INC·Filed 2008·Granted Oct 25, 2011·5 cites·20 claims
- 1181US5409946AIsoxazole, isothiazole and pyrazole compounds that enhance cognitive functionABBOTT LAB·Filed 1993·Granted Apr 25, 1995·50 cites·13 claims
- 1280US7507564B2Tiacumicin productionOPTIMER PHARMACEUTICALS INC·Filed 2003·Granted Mar 24, 2009·15 cites·10 claims
- 1379US8445654B2Antibiotic macrocycle compounds and methods of manufacture and use thereofICHIKAWA YOSHI·Filed 2011·Granted May 21, 2013·6 cites·8 claims
- 1478US8916527B2Antibiotic macrocycle compounds and methods of manufacture and use thereofOPTIMER PHARMACEUTICALS INC·Filed 2013·Granted Dec 23, 2014·3 cites·12 claims
- 1577US5340802APeptide analog type-B CCK receptor ligandsABBOTT LAB·Filed 1993·Granted Aug 23, 1994·47 cites·11 claims
- 1676US7906489B218-membered macrocycles and analogs thereofOPTIMER PHARMACEUTICALS INC·Filed 2007·Granted Mar 15, 2011·2 cites·14 claims
- 1776US5726195AAminoacyl adenylate mimics as novel antimicrobial and antiparasitic agentsCUBIST PHARM INC·Filed 1996·Granted Mar 10, 1998·21 cites·50 claims
- 1871US11583577B2Cancer immunotherapy by immune activation or immune modulation via Globo series antigensOBI PHARMA INC·Filed 2017·Granted Feb 21, 2023·1 cites·31 claims
- 1971US8586551B218-membered macrocycles and analogs thereofSHUE YOUE-KONG·Filed 2009·Granted Nov 19, 2013·1 cites·6 claims
- 2070US8728796B2Tiacumicin productionSHUE YOUE-KONG·Filed 2012·Granted May 20, 2014·2 cites·15 claims
- 2163US5270302ADerivatives of tetrapeptides as CCK agonistsABBOTT LAB·Filed 1991·Granted Dec 14, 1993·23 cites·10 claims
- 2261US2019062342A1Novel antibacterial agentsMERCK SHARP & DOHME·Filed 2018·Application pending·0 cites
- 2360US2013252914A1Macrolide Polymorphs, Compositions Comprising Such Polymorphs, and Methods of Use and Manufacture ThereofOPTIMER PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2458US2010028970A1Medium for the Production of Tiacumicin BSHUE YOUE-KONG·Filed 2009·Application pending·0 cites
- 2558US2007105791A1Method of treating clostridium difficile-associated diarrheaOPTIMER PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2656US2014296498A1Tiacumicin ProductionOPTIMER PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2756US2013252913A118-Membered Macrocycles and Analogs ThereofOPTIMER PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2854US2007142326A1Treatment of a condition in a mammal with administration of aminosugar and uses thereofSHUE YOUE-KONG·Filed 2004·Application pending·0 cites
- 2954US2016280718A1Novel antibacterial agentsMERCK SHARP & DOHME·Filed 2015·Application pending·0 cites
- 3054US2014107054A1Method of treating clostridium difficile-associated diarrheaOPTIMER PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 3150US2011166090A118-Membered Macrocycles and Analogs ThereofSHUE YOUE-KONG·Filed 2011·Application pending·0 cites
- 3248US2004058880A1Aminoglycoside antibiotics as novel anti-infective agentsFiled 2003·Application pending·0 cites
- 3347US2007173462A1Treatment of diseases associated with the use of antibioticsOPTIMER PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 3443US2013274175A1Treatment of disease associated with the use of antibioticsSHUE YOUE-KONG·Filed 2012·Application pending·0 cites
- 3539US2014315838A1Methods of Treating Recurring Bacterial InfectionOPTIMER PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3639US2013331347A1Treatment of Clostridium Difficile Infection in Patients Undergoing Antibiotic TherapyOPTIMER PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →